Conducting market research for scientific publication guide
Conducting and using market research for publication can be valuable for shaping opinions in healthcare. The findings can be used to influence existing perceptions, change current practices and behaviour in a particular disease area, and help both patients and physicians to make more informed decisions. Based on our expertise and experience of conducting market research for scientific publication in both developed and emerging markets across a wide range of therapy areas, we have put together a guide on how to establish medical credibility with your research.
Emerging Markets: Your New Essential Guide
Request your complimentary copy of our latest Emerging Markets guide.
Traditional and non-traditional emerging markets are increasingly being recognised by the pharmaceutical industry as offering attractive opportunities for growth. The challenge though is where and how to find insight in these less well-known and rapidly changing regions.
Using our combined knowledge and years of experience of working in these territories our emerging markets experts have produced this essential guide to help address some of the core challenges associated with conducting market research in emerging markets.
Understanding the Patient Journey guide
The patient journey is changing. Patients are now much more educated and engaged. They have access to information and want to be involved in decisions around their treatment programme. Technology is changing the way that healthcare is delivered and the way that patients experience healthcare. The journey is also more complex, with increasing number of healthcare professionals having to work together to provide care.
As pharma companies increasingly recognise the challenges of expecting physicians to carry the weight of their brand strategy, greater emphasis is being placed upon delivering services which ease the burden upon the physician and address the needs of other stakeholders involved in treating the patient.
Rare diseases: The market opportunity and market research considerations
Request your complimentary copy of our guide to rare diseases
Last year the FDA approved 48 drugs in rare diseases, including both novel and re-purposed drugs. The opportunity for rare diseases has become significant as manufacturers of orphan drugs are being awarded longer market exclusivity, reduced regulatory fees and tax incentives. However, commercialization of orphan drugs can be challenging, because of the size of patient populations, the cost of drugs, and the difficulty in diagnosing conditions. A successful product launch relies on insightful market intelligence to leverage the opportunity.
However, conducting effective research for rare diseases can be challenging. Drawing upon our considerable experience of managing both small and large scale studies across a number of different diseases, we have created a guide outlining the key steps required to implement an effective market research programme.
How the opportunity for a product treating a rare haematology disease in Emerging Markets was evaluated using a multi-stakeholder approach
Our client wanted to determine how to maximise the commercial opportunities for a product indicated for a rare disease in a range of emerging markets
Research Partnership recently conducted a study to determine how to maximise the commercial opportunities for a product indicated for a rare disease in a range of emerging markets. A three-phase methodology was utilised and gave the client in-depth insights into the specific opportunities and challenges as well as clear recommendations on the execution of strategy and tactical approach required to successfully maximise the product opportunity for each individual market.